Nanotech start-up offers 3D picture of a cell
Researchers at Washington University in St. Louis have launched a nanotech company--called PixelEXX Systems--which intends to advance the use of nanoarrays in drug research. The founders say that nanosensors can now produce an accurate 3D image of a cell that can measure its response to a drug.
"Nanoarrays are a new way of imaging cells," said Dr. Samuel Wickline in a statement. "A researcher can look at a living cell with nano-sized sensors to get a more detailed picture of the cell, its internal structures, and how those parts function."
- read the report fom the St. Louis Business Journal
Related Articles:
Nanotech is promising, but faces hurdles
Nanotech investment will have payoff
Tips for funding a biotech start-up
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


